Heart Test Laboratories
HSCS
10 hedge funds and large institutions have $579K invested in Heart Test Laboratories in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and closing their positions.
55% more capital invested
Capital invested by funds: $372K → $579K (+$206K)
43% more funds holding
Funds holding: 7 → 10 (+3)
0.01% more ownership
Funds ownership: 0.05% → 0.06% (+0.01%)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$116K |
| 2 |
TWM
Tradition Wealth Management
Edina,
Minnesota
|
+$64.2K |
| 3 |
Two Sigma Investments
New York
|
+$20.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$15.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OLVIG
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
|
-$7.03K |
| 2 |
AWM
AE Wealth Management
Topeka,
Kansas
|
-$6.35K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.08K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.22K |
| 5 |
Renaissance Technologies
New York
|
-$270 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OLVIG
1
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| $155K | -$7.03K | -52 | -3% |
|
|
AWM
2
AE Wealth Management
Topeka,
Kansas
| $148K | -$6.35K | -47 | -3% |
|
|
TWM
3
Tradition Wealth Management
Edina,
Minnesota
| $86K | +$64.2K | +475 | +119% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $85K | +$116K | +860 | New |
|
|
CD
5
Chapin Davis
Baltimore,
Maryland
| $54.3K | – | – | – |
|
|
6
Renaissance Technologies
New York
| $22K | -$270 | -2 | -0.9% |
|
|
7
Two Sigma Investments
New York
| $15.1K | +$20.7K | +153 | New |
|
|
TSS
8
Two Sigma Securities
New York
| $11.1K | +$15.3K | +113 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $2K | -$6.08K | -45 | -64% |
|
|
10
UBS Group
Zurich,
Switzerland
| $1.09K | -$1.22K | -9 | -45% |
|
11
Wells Fargo
San Francisco,
California
| $11 | – | – | – |
|
HSCS Hedge Fund Activity: Q1 2023 in Review
10 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q1 2023, worth a combined $579K — up 55% from $372K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new HSCS positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 5 trimmed.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $116K. The largest seller was Oliver Lagore Vanvalin Investment Group, cutting an estimated $7.03K.
- 10 institutional investors held Heart Test Laboratories (HSCS) as of Q1 2023, up from 7 in Q4 2022.
- Funds reported $579K of Heart Test Laboratories stock for Q1 2023, up 55% quarter-over-quarter.
- 3 funds opened new Heart Test Laboratories positions in Q1 2023 and 0 closed out, a net change of +3 holders.
- The largest Heart Test Laboratories buyer in Q1 2023 was Royal Bank of Canada, an estimated $116K added.
- The largest Heart Test Laboratories seller in Q1 2023 was Oliver Lagore Vanvalin Investment Group, an estimated $7.03K sold.
Based on aggregated 13F filings for Q1 2023.